Proteros is a biotech company focused on enabling lead discovery for challenging targets. Proteros has established a profitable discovery service business with a best-in-class enabling technology platform for structure accelerated lead discovery. Their track record is proven by an outstanding project success rate. Proteros’ proprietary pipelineincludes highly disease relevant target classes such as kinases, epigenetic targets and GPCRs. Their success is built on unique know how and expertise in understanding the role of protein structures involved in protein and small molecule interactions that are responsible for the pathogenesis of many diseases.

Biotechnology

Proteros

Torsten Neuefeind

Steven L. Holshouser

George Buckley

Dr. Tanja Vukicevic

Peter Persigehl

The Leadership Team at Proteros is responsible for setting the strategic direction and operational oversight of the company. This team, comprised of the CEO, COO, and Vice Presidents of Business Development, drives growth initiatives, cultivates partnerships, and ensures alignment of Proteros' innovative discovery services with market needs. Their collective expertise enables Proteros to effectively navigate the biotech landscape and maximize the potential of its proprietary technology platform.

Leadership Team

About

Team members

Other teams at Proteros

Research and Development Team